               SEQUENCE LISTING

<110> DEBIOPHARM RESEARCH & MANUFACTURING S.A.
<120> Reactive conjugates

<130> 239708

<140> EP PCT/EP2021/078181
<141> 2021-10-12

<160> 3
<170> BiSSAP 1.3.6

<210> 1
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> peptide portion of compound, as shown in formula (7a) in the application as filed

<220> 
<221> MOD_RES
<222> (1)..(1)
<223> Other groups or atoms, Z1 and Y1, as described on p. XY-XY of the application as filed

<220> 
<221> VARIANT
<222> (2)..(2)
<223> Represents a single covalent bond, or a trifunctional amino acid such as diamino-carboxylic acid

<220> 
<221> VARIANT
<222> (3)..(3)
<223> Represents an amino acid, a dicarboxylic acid, or a peptide moiety represented by formula (8a) on p. XY of the application as filed

<220>
<221> DISULFID
<222> (4)..(14)
<223>

<220> 
<221> VARIANT
<222> (5)..(5)
<223> Represents represents an amino acid as described on p. XY of the application as filed

<220> 
<221> VARIANT
<222> (6)..(10)
<223> Each independently represent an amino acid

<220> 
<221> VARIANT
<222> (15)..(15)
<223> Represents an amino acid, or a peptide moiety represented by formula (8b) on p. XY of the application as filed

<220> 
<221> VARIANT
<222> (16)..(16)
<223> Represents a single covalent bond, or a trifunctional amino acid such as diamino-carboxylic acid 
         
<220> 
<221> MOD_RES
<222> (17)..(17)
<223> Other groups or atoms, Z2 and Y2, as described on p. XY-XY of the application as filed

<400> 1
Xaa Xaa Xaa Cys Xaa Xaa Xaa Xaa Xaa Xaa Leu Val Trp Cys Xaa Xaa Xaa
1               5                   10              	15

<210> 2
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Fc-III-FAM, as shown on p.XYZ of the application as filed

<220>
<221> DISULFID
<222> (2)..(12)
<223>

<220> 
<221> MOD_RES
<222> (13)..(13)
<223> FAM label, as shown on p. XYZ of the application as filed

<400> 3
Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr
1               5                   10       

<210> 3
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> reference vector, as shown on page XYZ of the application as filed

<220> 
<221> MOD_RES
<222> (1)..(1)
<223> ACETYLATION

<220> 
<221> VARIANT
<222> (8)..(8)
<223> Represents lysine or ornithine
         
<220> 
<221> MOD_RES
<222> (17)..(17)
<223> AMIDATION

<400> 1
Arg Gly Asn Cys Ala Tyr His Xaa Gly Gln Ile Ile Trp Cys Thr Tyr His
1               5                   10              	15       